Related Experiment Video
Updated: Apr 17, 2026
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 4. Medical Imaging Procedures
Published on: October 3, 2016
Infection prevention and the medical director: uncharted territory
Toros Kapoian1, Klemens B Meyer2, Douglas S Johnson3
1Associate Professor of Medicine, Rutgers-Robert Wood Johnson Medical School, Department of Medicine, Division of Nephrology New Brunswick, New Jersey; Medical Director, Dialysis Clinic, Inc., North Brunswick, New Jersey;
Insights
Dialysis Medical Directors must lead efforts to reduce central venous hemodialysis catheter use, a major cause of infection and death. Educating staff and patients, and improving facility policies are key to better patient outcomes.
Area of Science:
- Nephrology
- Infectious Diseases
- Healthcare Management
Background:
- Infections remain a significant cause of morbidity and mortality in patients undergoing dialysis.
- Central venous hemodialysis catheters are frequently the initial mode of access, despite evidence supporting their avoidance.
- A gap exists between recommended practices and actual patient care regarding hemodialysis access.
Purpose of the Study:
- To emphasize the critical role of Dialysis Medical Directors in driving change within the dialysis industry.
- To advocate for comprehensive education of dialysis staff and patients on best practices for vascular access.
- To empower Dialysis Medical Directors with strategies for improving quality of care and patient safety.
Main Methods:
- Review of current practices and evidence regarding hemodialysis vascular access.
- Analysis of the impact of facility policies and regulatory differences on patient care.
- Emphasis on leadership, education, and data-driven quality improvement processes.
Main Results:
- Dialysis Medical Directors are pivotal in initiating and sustaining changes in hemodialysis practices.
- Effective change requires continuous education, policy adherence, and leading by example.
- Data collection, analysis, and action are essential for meaningful process improvement.
Conclusions:
- Dialysis Medical Directors must actively lead initiatives to minimize hemodialysis catheter use.
- A multi-faceted approach involving education, policy alignment, and quality improvement is necessary.
- Empowering Dialysis Medical Directors with tools and strategies can significantly enhance patient care and outcomes.
Abstract:
Infections continue to be a major cause of disease and contributor to death in patients on dialysis. Despite our knowledge and acceptance that hemodialysis catheters should be avoided and eliminated, most patients who begin dialysis initiate treatment through a central vein hemodialysis catheter. Dialysis Medical Directors must be the instrument through which our industry changes. We must lead the charge to educate our dialysis staff and our dialysis patients. We must also educate ourselves so that we not only know that our facility policies are consistent with the best evidence available, but we must also know where local and federal regulations differ. When these differences impact on patient care, we must speak out and have these regulations changed. But it is not enough to know the rules and write them. We must lead by example and show our patients, our nephrology colleagues and our dialysis staff that we always follow these same policies. We need to practice what we preach and be willing and available to redirect those individuals who have difficulty following the rules. In order to effectively change process meaningful data must be collected, analyzed and acted upon. Dialysis Medical Directors must direct and lead the quality improvement process. We hope this review provides Dialysis Medical Directors with the necessary tools to effectively drive this process and improve care.
Related Concept Videos
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:26Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
01:20Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
01:18Endocarditis III: Medical Management
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...